COYA
Price
$5.96
Change
-$0.13 (-2.13%)
Updated
Nov 13 closing price
Capitalization
124.08M
Intraday BUY SELL Signals
GPCR
Price
$36.90
Change
+$1.90 (+5.43%)
Updated
Nov 14, 11:28 AM (EDT)
Capitalization
2.12B
Intraday BUY SELL Signals
Interact to see
Advertisement

COYA vs GPCR

Header iconCOYA vs GPCR Comparison
Open Charts COYA vs GPCRBanner chart's image
Coya Therapeutics
Price$5.96
Change-$0.13 (-2.13%)
Volume$211.23K
Capitalization124.08M
Structure Therapeutics
Price$36.90
Change+$1.90 (+5.43%)
Volume$300
Capitalization2.12B
COYA vs GPCR Comparison Chart in %
COYA
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COYA vs. GPCR commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and GPCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (COYA: $5.96 vs. GPCR: $35.00)
Brand notoriety: COYA and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 112% vs. GPCR: 169%
Market capitalization -- COYA: $124.08M vs. GPCR: $2.12B
COYA [@Biotechnology] is valued at $124.08M. GPCR’s [@Biotechnology] market capitalization is $2.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileGPCR’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • GPCR’s FA Score: 1 green, 4 red.
According to our system of comparison, GPCR is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 2 TA indicator(s) are bullish while GPCR’s TA Score has 5 bullish TA indicator(s).

  • COYA’s TA Score: 2 bullish, 9 bearish.
  • GPCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а +3.47% price change this week, while GPCR (@Biotechnology) price change was +4.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($2.12B) has a higher market cap than COYA($124M). GPCR YTD gains are higher at: 29.056 vs. COYA (4.014). COYA has higher annual earnings (EBITDA): -22.59M vs. GPCR (-218.56M). GPCR has more cash in the bank: 786M vs. COYA (29.8M). COYA has higher revenues than GPCR: COYA (423K) vs GPCR (0).
COYAGPCRCOYA / GPCR
Capitalization124M2.12B6%
EBITDA-22.59M-218.56M10%
Gain YTD4.01429.05614%
P/E RatioN/AN/A-
Revenue423K0-
Total Cash29.8M786M4%
Total DebtN/A7.68M-
TECHNICAL ANALYSIS
Technical Analysis
COYAGPCR
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVBXF11.880.97
+8.84%
Innovent Biologics Inc.
IVEVF4.44N/A
N/A
INVENTIVA SA
LSFG49.01N/A
N/A
Lifestore Financial Group, Inc.
KYYHF23.10N/A
N/A
Kyushu Railway Co
PSYCF0.01N/A
-11.48%
Psyched Wellness Ltd.

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with GANX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then GANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-2.13%
GANX - COYA
42%
Loosely correlated
+1.36%
KNSA - COYA
42%
Loosely correlated
-0.71%
ATXS - COYA
38%
Loosely correlated
-0.88%
BMRN - COYA
34%
Loosely correlated
-1.99%
GPCR - COYA
33%
Poorly correlated
-2.56%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.56%
CLDX - GPCR
44%
Loosely correlated
-2.19%
SYRE - GPCR
44%
Loosely correlated
-3.41%
IMTX - GPCR
43%
Loosely correlated
-6.47%
VKTX - GPCR
43%
Loosely correlated
-4.36%
EYPT - GPCR
42%
Loosely correlated
-4.00%
More